UK government pushes ahead with value based pricing of drugsBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d4632 (Published 20 July 2011) Cite this as: BMJ 2011;343:d4632
- Nigel Hawkes
The government intends to go ahead with its plan to set prices of drugs in the United Kingdom by the value they deliver, in spite of a lukewarm response to the proposal.
The consultation on value based pricing, published on Monday 18 July, shows that many of the 188 respondents remain unconvinced. In answer to the key question, “Will the approach achieve the proposed objectives of better patient outcomes, greater innovation, a broader and more transparent assessment, and better value for money for the NHS?” only 15% of respondents said yes, while 19% said no and 66% did not answer.
The Department of …